AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Debiglip-M Tablet

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Debiglip-M Tablet

Diabetam-Duo tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, and may lessen the risk of stroke or heart attack. Diabetam-Duo may be used alone or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular exercise. Dosage is individualized based on your health, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. It actively controls blood sugar, mitigating future complications. Adherence to your doctor's dietary and exercise plan is crucial. Lifestyle significantly impacts diabetes management. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, throat irritation, fatigue, GERD, excessive perspiration, and reduced appetite. Hypoglycemia is a potential side effect, especially when used with insulin or sulfonylureas; learn to recognize and address its symptoms. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its blood sugar-lowering effects. Kidney function and blood glucose levels are monitored before and throughout treatment.

Primary Ingredients of Debiglip-M Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Debiglip-M Tablet

Managing type 2 diabetes

Major Benefits of Debiglip-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Debiglip-M Tablet with a meal.

Common Side effects of Debiglip-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Debiglip-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Debiglip-M Tablet with a meal.

How Debiglip-M Tablet works:

Metformin and glimepiride are combined in Debiglip-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Debiglip-M Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Debiglip-M Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Debiglip-M tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Debiglip-M Tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Debiglip-M Tablets is contraindicated in individuals with hepatic impairment; patients with liver disease should not take this medication and must seek medical advice.

What if you forget to take Debiglip-M Tablet :

Should you forget a Debiglip-M Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.

Facts to Know About Debiglip-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Debiglip-M Tablet

Debiglip-M Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Debiglip-M Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Debiglip-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Debiglip-M Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Debiglip-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding Debiglip-M in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Debiglip-M and seek immediate medical attention.
Prolonged Debiglip-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Debiglip-M Tablets are safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Debiglip-M Tablet
189
MRP 230
17% off